Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00079573 · ClinicalTrials.gov registry record · Phase 2
Comparison of Popular Weight Loss Diets
A Phase 2 study of Obesity, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 2
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT00079573 is a Phase 2 study of Obesity that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 300 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00079573, a Phase 2 study of Obesity, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will compare the safety and effectiveness of three popular weight loss plans. These plans will be compared with the USDA Dietary Guidelines.
Conditions Studied
Interventions
- BEHAVIORAL Atkins diet (extremely low carbohydrate)
- BEHAVIORAL Zone diet (low carbohydrate, high protein)
- BEHAVIORAL Ornish diet (very low fat)
Study Locations (1)
California
- Stanford Prevention Research Center - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2002-07 |
| Est. Completion | 2004-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00079573
The ClinicalTrials.gov registry entry for NCT00079573 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (63% lower). The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Atkins diet (extremely low carbohydrate) is the first listed.
NCT00079573 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00079573 about?
NCT00079573 is a clinical study titled "Comparison of Popular Weight Loss Diets". This study will compare the safety and effectiveness of three popular weight loss plans. These plans will be compared with the USDA Dietary Guidelines.
What is the current status of trial NCT00079573?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 300 participants. The study started on 2002-07. Estimated completion is 2004-06.
What conditions does trial NCT00079573 study?
This clinical trial studies the following conditions: Obesity.
What interventions are being tested in trial NCT00079573?
The interventions under investigation include: Atkins diet (extremely low carbohydrate) (BEHAVIORAL), Zone diet (low carbohydrate, high protein) (BEHAVIORAL), Ornish diet (very low fat) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00079573?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00079573 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Convergent Mechanisms Underlying Reprometabolic Syndrome in Women
RECRUITING · Phase 2
-
Arterial Destiffening Effects of SGLT2 Inhibition in Veterans With Obesity
RECRUITING · Phase 2
-
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
RECRUITING · Phase 2
-
Pharmacological and Behavioral Treatment After Bariatric Surgery
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.